MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

January 2003


Tenecteplase: Innovative Fibrinolysis for ST-Segment Elevation Myocardial Infarction (STEMI)

When combined with potent antiplatelet agents and low-molecular-weight heparins, tenecteplase has demonstrated improved patient outcomes.
Gordon J. Vanscoy, PharmD, CACP, MBA, Thomas L. Rihn, PharmD, and Pamela H. Koerner, PharmD

Symposium Overview: Present Clinical Drug Trial Programs for the Treatment of Lymphoma

The author reviews vaccine studies, combination rituximab trials, and developments with antisense therapy, proteosome inhibitors, and promising monoclonal antibodies.
Marvin M. Goldenberg, PhD, RPh, MS

Unit-Specific Pharmacists: A Proactive Approach to the Continuum of Care

Using a unit-specific pharmacist allows smaller hospitals to focus on patient care with greater flexibility and minimal increases in staffing.
Jeffrey G. Santorello, MS, RPh, Olga Larios, MS, RPh, and Joseph Dougherty, RPh



Turning Errors into Gold

Editor-in-Chief David Nash explains how public disclosure of health plan performance can “turn errors into gold.”
David B. Nash, MD, MBA

Medication Errors

Failure Mode and Effects Analysis Can Help Guide Error-Prevention Efforts

Mr. Grissinger discusses how failure mode and effects analysis can help guide error-prevention efforts.
Matthew Grissinger

Drug News

New Drugs/Drug News

The latest information about approvals, indication changes, industry updates, and news from the FDA.

Prescription Washington

Some Drug Ads Don’t “Ad” Up

Mr. Barlas questions the veracity of some direct-to-consumer drug ads.
Stephen Barlas

Drug Forecast

Adefovir Dipivoxil: A New Agent For Active Hepatitis B Virus Infectio

The authors review a new agent, adefovir dipivoxil, for the treatment of active hepatitis B virus infection.
Tarrah Williams, PharmD Candidate, Marlon Honeywell, PharmD, Evans Branch III, PharmD, and Frank Emanuel, PharmD

P&T Snapshot

Hospital Treatment Practices for Acute Myocardial Infarction

A review of six years of hospital data shows a steady increase in the use of aspirin, antiplatelets, and beta blockers.